Novartis AG (NVS)

88.12 +0.32  +0.36% NYSE Jul 8, 20:00 Delayed 2m USD

Novartis PE Ratio:

16.82 for July 8, 2020
View 4,000+ financial data types
Browse...
View Full Chart

PE Ratio Chart

Export Data
Save Image
Print Image

Historical PE Ratio Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
July 8, 2020 16.82
July 7, 2020 16.76
July 6, 2020 16.88
July 2, 2020 16.71
July 1, 2020 16.77
June 30, 2020 16.67
June 29, 2020 16.67
June 26, 2020 16.62
June 25, 2020 17.10
June 24, 2020 16.95
June 23, 2020 17.26
June 22, 2020 17.29
June 19, 2020 17.39
June 18, 2020 17.11
June 17, 2020 17.08
June 16, 2020 16.56
June 15, 2020 16.25
June 12, 2020 16.10
June 11, 2020 16.11
June 10, 2020 16.79
June 9, 2020 16.88
June 8, 2020 16.35
June 5, 2020 16.39
June 4, 2020 16.24
June 3, 2020 16.36
   
June 2, 2020 16.50
June 1, 2020 16.54
May 29, 2020 16.69
May 28, 2020 16.47
May 27, 2020 16.12
May 26, 2020 16.23
May 22, 2020 16.20
May 21, 2020 16.22
May 20, 2020 16.40
May 19, 2020 16.27
May 18, 2020 16.19
May 15, 2020 16.03
May 14, 2020 16.04
May 13, 2020 16.26
May 12, 2020 16.25
May 11, 2020 16.52
May 8, 2020 16.21
May 7, 2020 16.16
May 6, 2020 16.29
May 5, 2020 16.17
May 4, 2020 16.03
May 1, 2020 15.92
April 30, 2020 16.17
April 29, 2020 16.36
April 28, 2020 16.80

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Benchmarks

Benchmarks
AstraZeneca PLC 94.24
Gilead Sciences Inc 19.44
Johnson & Johnson 22.35

PE Ratio Range, Past 5 Years

Minimum 9.768 Feb 29 2016
Maximum 32.46 Jun 22 2017
Average 20.68
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.